For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs ...
A novel regimen of doravirine and islatravir was noninferior to a common HIV therapy as an initial HIV treatment, according ...
Research on best options is sparse, but biologics can still be helpful for HIV-positive patients with psoriasis.
Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on ...
A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in ...
Understanding the benefits of early treatment for HIV is crucial for managing the disease effectively. Starting treatment soon after diagnosis not only preserves health but also enhances the quality ...
Please provide your email address to receive an email when new articles are posted on . A combination of doravirine (DOR) and islatravir (ISL) was noninferior to current suppressive therapies among ...
Researchers conducted a retrospective study to evaluate changes in blood pressure and various metabolic parameters among patients with acute HIV infection who initiated either EFV- or DTG-based ...
HIV treatment has delivered life-altering advantages. Antiretroviral therapy has led to reduced mortality and improved life expectancy for people living with HIV. Nearly 41 million people were living ...
What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best ...
A wave of under-the-radar HIV policy changes is unfolding nationwide, with advocates warning of serious, far-reaching consequences.
The Cebu Provincial Health Office (CPHO), led by focal person Wilfredo Ocampo Selgado Jr., is intensifying its HIV prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results